Artos
Artos is an AI-powered document creation and management platform that helps life sciences teams (large pharma, biotech, CROs) draft and manage regulatory submission documents (INDs, NDAs, BLAs, CSRs, CMC) faster, with traceability and GxP compliance.
- Company typePrivate
- Founded2023
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Artos does
Artos is a Y Combinator-backed, San Francisco-based software company that builds an AI-powered document creation and management platform for life sciences organizations preparing regulatory submissions. Founded in 2023 and operating with a team of 1–10, the company targets medical writing, CMC, regulatory affairs, regulatory intelligence, IT, and engineering functions within large pharmaceutical companies, small and mid-sized pharma, capital-constrained biotechs, and CRO/medical writing firms. The platform covers the full document lifecycle for INDs, NDAs, and BLAs across the CTD pyramid, including Clinical Study Reports, Non-Clinical Overviews, CMC documents, Module 2 Written Summaries, Investigator's Brochures, and Quality Overall Summaries.
The platform's core technology is an agentic modular architecture composed of discrete, reusable agents (data extraction, information retrieval, content reuse, table analysis, summarization, conclusion drafting, QC) orchestrated for each document type rather than relying on generic LLM prompts. Artos combines deterministic software with generative AI for reliability, processes multi-modal inputs including tables, figures, scanned PDFs, and handwritten notes, and embeds purpose-built AI systems co-developed with subject matter experts. Differentiated capabilities include Source Tracer (traceability of every generated section back to original data, validated against tens of thousands of tables), Inconsistency Intelligence (cross-document change-impact tracking), Auditable Automations with GxP validation logic, custom templates, and HL7 FHIR data standards support. Integrations span Veeva RIM, SharePoint, Google Drive, Box, and Microsoft Teams, and the platform is SOC2 Type 2 compliant, GDPR-compliant, and designed for GxP software requirements.
Artos operates a SaaS subscription revenue model with quote-based enterprise pricing for large organizations (typically multi-year contracts) and a self-serve monthly signup tier for smaller buyers. Distribution combines enterprise field sales targeting large pharma, biotech, and CROs — anchored by a 'Book Demo' call-to-action — with content marketing, free eCTD templates, and an active presence at industry events such as DIA, RAPS Convergence, BioTechX USA, AMWA, and JPM Healthcare. The company is led by co-founder and CEO Josh Kim and co-founder Varun Patel, with a team that includes AI governance and adoption specialists. Disclosed funding totals $500,000 from a February 2024 seed round led by Y Combinator with Pioneer Fund participation; no revenue, ARR, or customer count has been publicly disclosed.
Artos firmographics
Firmographics- Name
- Artos
- Legal name
- Artos
- Website
- https://www.artosai.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Artos is an AI-powered document creation and management platform that helps life sciences teams (large pharma, biotech, CROs) draft and manage regulatory submission documents (INDs, NDAs, BLAs, CSRs, CMC) faster, with traceability and GxP compliance.
- Ownership category
- akta.pro rank
Artos industry classification
Industry- Product category
- Regulatory Document Automation Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Intelligent Document Processing (IDP) & OCR Automation (HDAEAHAC)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)
Keywords
Where Artos is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Artos business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription: Artos operates as a SaaS platform with subscription-based pricing. The company offers scalable pricing models designed to be cost-effective compared to building AI systems internally. Pricing is positioned as up to 20x cheaper per employee than internal development.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise tier for large organizations |
| Subscription | Monthly | Self-serve/online signup option |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
Artos product offering
Product offeringCore offering
Artos provides an AI-powered document drafting and management SaaS platform that converts life sciences data and reports into submission-ready regulatory packages for INDs, NDAs, and BLAs. The platform delivers purpose-built generative AI for each document type (Clinical Study Reports, Non-Clinical Overviews, Module 2 summaries, CMC documents, Investigator's Brochures) with full source traceability, multi-modal support for tables and figures, GxP-compliant automations, and integrations with Veeva RIM, SharePoint, Box, and Google Drive.
Product overview
Artos is an AI-powered document creation and management platform for the life sciences industry, consisting of a unified platform with integrated modules. The core platform includes Document Drafting, Source Tracer, Inconsistency Intelligence, Custom Templates, Section Regeneration, Audit Logs, Search, and Automations. These modules work together as an end-to-end suite handling the entire CTD pyramid from raw data to final draft for INDs, NDAs, and BLAs. The platform serves various team functions including Medical Writing, CMC, Regulatory Affairs, Regulatory Intelligence, IT, and Engineering, with solutions optimized for Large Pharma, Medium Pharma, Biotech, and CRO/Medical Writing Firms organizations.
Differentiator
Problem solved
Functional benefit
Products and services
- Artos Platform End-to-end AI-powered SaaS platform for life sciences document creation and management across the entire CTD pyramid, from raw data to final draft for INDs, NDAs, and BLAs. The unified suite delivers Document Drafting, Source Tracer, Inconsistency Intelligence, Custom Templates, Section Regeneration, Audit Logs, Search, and Automations, with integrations to Veeva RIM, SharePoint, Box, and Google Drive, and supports HL7 FHIR standards. Purpose-built AI systems exist for each document type — Clinical Study Reports, Non-Clinical Overviews, Module 2 Written Summaries, CMC documents, Investigator's Brochures, Quality Overall Summaries, Tabulated Summaries, and more. Sold primarily via enterprise subscription with deployment in under 7 days and value realization within 2 weeks, also available via self-serve online signup for smaller organizations. SOC2-compliant, GDPR-compliant, and GxP-ready.
Quantifiable outcome
- Time savings of 50-80% on document drafting and review cycles
- +6 more outcomes
Companies that use Artos
Customer profileSegments5 records
Ideal customer profiles4 records
Artos technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability10 records
Feature8 records
Artos partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- VeevacoreHigh-fidelity integration with Veeva RIM, the most widely used document management system for regulatory submissions. Allows seamless document management within existing regulatory workflows.
- SharePointcoreIntegration to read, write, and manage documents from SharePoint accounts directly within the Artos platform.
- Google DrivecoreSeamless integration allowing users to read, write, and manage documents from Google Drive accounts within Artos.
- BoxcoreIntegration to sync and manage documents with company Box systems for seamless document management workflows.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
Artos competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva is the dominant cloud software provider for life sciences, including the Veeva Vault RIM platform for regulatory information management. Artos integrates with Veeva RIM and competes for the same regulated-document workflows, but Veeva offers a far broader portfolio across clinical, regulatory, quality, and commercial.
- IQVIA: IQVIA is a global CRO and life sciences technology vendor offering regulatory, clinical, and AI-driven analytics solutions. It competes for the same pharmaceutical medical writing and regulatory operations budgets that Artos targets, particularly with its AI-augmented offerings across the drug development lifecycle.
- Medidata (Dassault Systèmes): Medidata provides clinical trial technology including EDC and CTMS as part of the Dassault Systèmes 3DEXPERIENCE platform. It serves overlapping pharma clinical and regulatory workflows and has begun embedding AI features that could encroach on Artos's authoring wedge.
Direct peers
- Certara: Certara provides regulatory and scientific software and services including regulatory writing, submission management, and biosimulation for pharma. Its D360 and submission management tools directly overlap with Artos's regulatory document drafting and CTD-authoring focus, serving the same medical writing teams.
- ArisGlobal: ArisGlobal offers LifeSphere Regulatory and Safety platforms for life sciences, including document and submission management. It targets the same pharma regulatory operations buyers as Artos and increasingly integrates AI features into its regulatory product suite.
- Kneat Solutions: Kneat provides digital validation and regulated document lifecycle management software for life sciences, including electronic validation and document authoring workflows. It addresses similar GxP-compliant authoring and review use cases in pharma and biotech.
- Yseop: Yseop is an AI-driven natural language generation platform with deep presence in life sciences regulatory and medical writing automation. It is the most direct AI-native competitor to Artos in automating clinical study reports and regulatory submission narratives.
Emerging players
- Saama Technologies: Saama offers AI-driven clinical development and regulatory analytics for life sciences, including clinical data management and submission insights. It overlaps with Artos in using AI to accelerate regulatory and clinical workflows for pharma and biotech.
- ComplianceQuest: ComplianceQuest provides AI-enabled quality, document, and regulatory management software on Salesforce for life sciences manufacturers. It targets overlapping GxP-regulated document and change management use cases but with a broader QMS focus rather than authoring-specific AI.
Others
- OpenAI (ChatGPT Enterprise): OpenAI's ChatGPT Enterprise and API are increasingly used by pharma medical writing teams for general-purpose drafting assistance. While not life sciences-specific, large pharma IT teams building internal AI stacks on OpenAI represent a credible alternative deployment path versus buying Artos.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Artos social profiles
Digital presenceArtos compliance and trust
Trust signalCompliance3 records
Artos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Artos leadership team
Management profileNumber of profiles
Profiles3 records
Artos funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Artos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Artos
What does Artos do?
Artos provides an AI-powered document drafting and management SaaS platform that converts life sciences data and reports into submission-ready regulatory packages for INDs, NDAs, and BLAs. The platform delivers purpose-built generative AI for each document type (Clinical Study Reports, Non-Clinical Overviews, Module 2 summaries, CMC documents, Investigator's Brochures) with full source traceability, multi-modal support for tables and figures, GxP-compliant automations, and integrations with Veeva RIM, SharePoint, Box, and Google Drive.
Is Artos a public or private company?
Artos is a private company. It is classified as venture growth investor backed and is currently operating.
When was Artos founded?
Artos was founded in 2023. It employs 1 to 10 people.
Where is Artos based?
Artos is headquartered in San Francisco, United States, in the North America region.
How does Artos make money?
One revenue line is on record: saaS Subscription.
Who are Artos's main competitors?
Broad incumbents on record are Veeva Systems, IQVIA and Medidata (Dassault Systèmes). Direct peers are Certara, ArisGlobal, Kneat Solutions and Yseop. Emerging players are Saama Technologies and ComplianceQuest. OpenAI (ChatGPT Enterprise) is listed as an others.
Does Artos have an API?
Yes. Artos offers an API designed to smooth over the difficult parts of building AI systems for the life sciences. The API enables data transformation for GxP-compliant workflows including mappings, database storage, and document management; deployment transparency through audit logs; and content extraction from complex formats.
What industry is Artos in?
Artos's product category is Regulatory Document Automation Software. Its primary akta.pro industry code is HDAEAHAC, Intelligent Document Processing (IDP) & OCR Automation, with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 513210 and its SIC code is 7372.